Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov-Dec;37(7):1832-1836.
doi: 10.12669/pjms.37.7.4518.

Evaluation of outcomes of medication therapy management (MTM) services for patients with chronic obstructive pulmonary disease (COPD)

Mingyue Liu  1 , Jiayun Liu  2 , Zhihui Geng  3 , Shuang Bai  4
Affiliations

Evaluation of outcomes of medication therapy management (MTM) services for patients with chronic obstructive pulmonary disease (COPD)

Mingyue Liu et al. Pak J Med Sci. 2021 Nov-Dec.

Abstract

Objectives: To evaluate the outcomes of clinical pharmacist-led medication therapy management (MTM) services for patients with chronic obstructive pulmonary disease (COPD).

Methods: Two hundred COPD patients admitted by the Department of Respiratory and Critical Care Medicine of Baoding No.1 Central Hospital during January 2019 and December 2020 were randomly assigned to a control group (n =100) and an experimental group (n =100). Patients in the control group received conventional treatment, while those in the experimental group were provided with MTM services based on the conventional treatment for comparative analysis of outcome measures, including use of antibacterials during hospital stay, length of stay (LoS), costs of hospitalization (CoH), cases of adverse drug reactions (ADRs), and medication adherence (MA) and COPD assessment test (CAT) score one and six months after discharge.

Results: Compared with the control group, the experimental group had reduced use of antibacterials during hospital stay, LoS, CoH, and ADR rate (P <0.05). After discharge, patients in both groups showed remarkable improvements in MA and CAT scores in comparison with their performances upon admission, and the experimental group exhibited better MA and higher CAT score than the control group, with the differences indicating statistical significance (P <0.05).

Conclusion: MTM designed for COPD patients can improve pharmacist-led service quality and clinical outcomes of COPD.

Keywords: Medication therapy management (MTM); chronic obstructive pulmonary disease (COPD); outcome.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors declare that there is no conflict of interest.

References

    1. Rodriguez-Roisin R, Rabe KF, Vestbo J, Vogelmeier C, Agustí A. all previous and current members of the Science Committee and the Board of Directors of GOLD (goldcopd.org/committees/). Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary:a brief history of time. Eur Respir J. 2017;50(1):1700671. DOI:10.1183/13993003.00671-2017. - PubMed
    1. Duong M, Islam S, Rangarajan S, Teo K, O'Byrne PM, Schunemann HJ, et al. Global differences in lung function by region (PURE):an international, community-based prospective study. Lancet Respir Med. 2013;1(8):599–609. DOI:10.1016/S2213-2600(13)70164-4. - PubMed
    1. Bindu Murali A, Boban B, Karoor Shanmughan A, Marimuthu K, Ramakrishnan Sreelatha A, Xavier A. Medication therapy management (MTM):an innovative approach to improve medication adherence in diabetics. Drug Metab Pers Ther. 2016;31(3):151–155. DOI:10.1515/dmpt-2016-0016. - PubMed
    1. Bullard WPB. Medication therapy management services. J Natl Med Assoc. 2008;100(4):454–455.
    1. Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, et al. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci. 2010;32(3):394–403. DOI:10.1007/s11096-010-9385-x. - PubMed

LinkOut - more resources